SMS Lifesciences India バランスシートの健全性
財務の健全性 基準チェック /46
SMS Lifesciences Indiaの総株主資本は₹2.0B 、総負債は₹894.9Mで、負債比率は44%となります。総資産と総負債はそれぞれ₹3.9Bと₹1.9Bです。 SMS Lifesciences Indiaの EBIT は₹307.4Mで、利息カバレッジ比率3.3です。現金および短期投資は₹11.9Mです。
主要情報
44.0%
負債資本比率
₹894.94m
負債
| インタレスト・カバレッジ・レシオ | 3.3x |
| 現金 | ₹11.92m |
| エクイティ | ₹2.03b |
| 負債合計 | ₹1.88b |
| 総資産 | ₹3.91b |
財務の健全性に関する最新情報
Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Aug 01
SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky
Feb 10SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt
Jun 03Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Feb 22Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?
Nov 24Recent updates
Earnings Working Against SMS Lifesciences India Limited's (NSE:SMSLIFE) Share Price Following 25% Dive
Nov 14Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified
Aug 27Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Aug 01SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market
Jun 13SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky
Feb 10There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump
Jan 05Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?
Sep 23SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50
Sep 07SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50
Aug 24SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 16SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 02SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt
Jun 03With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting
May 13SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals
Nov 23Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?
Jun 21Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Feb 22SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Jan 04Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares
Nov 27Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?
Nov 24財務状況分析
短期負債: SMSLIFEの 短期資産 ( ₹1.5B ) が 短期負債 ( ₹1.4B ) を超えています。
長期負債: SMSLIFEの短期資産 ( ₹1.5B ) が 長期負債 ( ₹441.0M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: SMSLIFEの 純負債対資本比率 ( 43.4% ) は 高い と見なされます。
負債の削減: SMSLIFEの負債対資本比率は、過去 5 年間で42%から44%に増加しました。
債務返済能力: SMSLIFEの負債は 営業キャッシュフロー によって 十分にカバー されています ( 37.4% )。
インタレストカバレッジ: SMSLIFEの負債に対する 利息支払い は EBIT ( 3.3 x coverage) によって 十分にカバーされています。